Med’s Betul Hatipoglu talks about use of Ozempic

FDA adds new gastrointestinal side effect warning to Ozempic label
HealthBetul Hatipoglu, professor of medicine and director of the Center for Diabetes, Obesity and Metabolism, said Ozempic shouldn’t be completely written off. “Being fearful [of] using the drug because of this rare side effect is not fair for patients who will benefit from it,” she said.